Hangzhou Tigermed Consulting Balance Sheet Health
Financial Health criteria checks 6/6
Hangzhou Tigermed Consulting has a total shareholder equity of CN¥24.1B and total debt of CN¥3.6B, which brings its debt-to-equity ratio to 14.9%. Its total assets and total liabilities are CN¥30.4B and CN¥6.3B respectively. Hangzhou Tigermed Consulting's EBIT is CN¥1.5B making its interest coverage ratio -4.2. It has cash and short-term investments of CN¥3.2B.
Key information
14.9%
Debt to equity ratio
CN¥3.58b
Debt
| Interest coverage ratio | -4.2x |
| Cash | CN¥3.22b |
| Equity | CN¥24.07b |
| Total liabilities | CN¥6.35b |
| Total assets | CN¥30.42b |
Recent financial health updates
Recent updates
Hangzhou Tigermed Consulting Co., Ltd's (SZSE:300347) Share Price Could Signal Some Risk
Aug 21
Hangzhou Tigermed Consulting (SZSE:300347) Is Increasing Its Dividend To CN¥0.568
Jul 12Is Hangzhou Tigermed Consulting (SZSE:300347) A Risky Investment?
Jun 26An Intrinsic Calculation For Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Suggests It's 35% Undervalued
Jun 07Hangzhou Tigermed Consulting Co., Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 28Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Stock Catapults 27% Though Its Price And Business Still Lag The Market
Apr 08Hangzhou Tigermed Consulting's (SZSE:300347) Profits Appear To Have Quality Issues
Apr 04Hangzhou Tigermed Consulting Co., Ltd Just Missed Earnings - But Analysts Have Updated Their Models
Apr 01Financial Position Analysis
Short Term Liabilities: 300347's short term assets (CN¥7.6B) exceed its short term liabilities (CN¥5.3B).
Long Term Liabilities: 300347's short term assets (CN¥7.6B) exceed its long term liabilities (CN¥1.0B).
Debt to Equity History and Analysis
Debt Level: 300347's net debt to equity ratio (1.5%) is considered satisfactory.
Reducing Debt: 300347's debt to equity ratio has reduced from 16.5% to 14.9% over the past 5 years.
Debt Coverage: 300347's debt is well covered by operating cash flow (26.6%).
Interest Coverage: 300347 earns more interest than it pays, so coverage of interest payments is not a concern.